New perspectives in dendritic cell-based cancer immunotherapy

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
A Nencioni, P Brossart

Abstract

Dendritic cells are professional antigen-presenting cells with the unique capacity to initiate primary immune responses. Recently, several procedures to generate large numbers of dendritic cells from circulating precursors, including peripheral blood monocytes and CD34+ stem cells, have been developed. Stimulation with antigen-loaded dendritic cells was shown to break tolerance to tumour-associated antigens and to induce antitumour cytotoxic immune responses in vivo. Hence, numerous attempts to optimise delivery of tumour antigens to dendritic cells, as well as routes and schedules of administration to cancer patients, are currently under way. The first dendritic cell clinical studies have indicated this form of vaccination as feasible and safe; furthermore, in some cases, objective clinical responses were observed, even in patients heavily pretreated with standard chemo/radiotherapy approaches. These preliminary data, although encouraging, require further extensive investigations, which should address the technical and biological problems of manipulating human dendritic cells, as well as the clinical settings which could benefit from an immunotherapeutic approach.

References

Jan 1, 1991·Annual Review of Immunology·R M Steinman
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P S Freudenthal, R M Steinman
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·B MukherjiJ Meehan
Feb 1, 1995·Current Opinion in Immunology·H G Rammensee
Nov 1, 1994·Cancer Immunology, Immunotherapy : CII·G Stuhler, P Walden
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·L J Zhou, T F Tedder
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·R C FieldsJ J Mulé
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·G StuhlerS F Schlossman
May 14, 1999·Immunology Today·M RescignoP Ricciardi-Castagnoli
Jun 18, 1999·Annals of the New York Academy of Sciences·W BruggerL Kanz
Jul 1, 1999·The Prostate·B A TjoaG P Murphy
Jul 20, 1999·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj
Feb 12, 2000·European Journal of Immunology·M SalioA Lanzavecchia
Feb 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·V RussoC Traversari
Mar 17, 2000·Immunological Reviews·Y A Mekori, D D Metcalfe
Mar 23, 2000·The Journal of Clinical Investigation·M V DhodapkarN Bhardwaj

❮ Previous
Next ❯

Citations

Feb 17, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·John R YannelliEdward Hirschowitz
Nov 3, 2004·Vaccine·John R Yannelli, Joanne M Wroblewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.